Pharmaceutical giant Eli Lilly will exempt Arkansas covered entities from its latest 340B contract pharmacy restrictions in response to an [...] …
Category: Pharma Industry
The trial for drugmaker Novo Nordisk’s legal challenge to Arkansas’ 340B contract pharmacy law will wait a year to commence. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal district court transferred drugmaker Novo Nordisk’s lawsuit challenging Arkansas’ 340B contract pharmacy law to a judge who previously [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge allowed a Louisiana provider group to join the state attorney general in defending Louisiana’s 340B contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The average hospital in the 340B program charges commercial insurers more than non-340B hospitals, according to a new report, which [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
GlaxoSmithKline owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant Eli Lilly this week announced it would reinstate tighter 340B contract pharmacy restrictions for all covered entity types. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
An influential drug industry trade group recently urged a federal judge to rule on its suit against Louisiana’s 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Arkansas Insurance Department (AID) recently asked a federal district judge to dismiss Novo Nordisk’s lawsuit that challenges Arkansas’ state [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Organon, a Merck spinoff with a focus on women’s health, yesterday became the sixth drugmaker to loosen or end its [...] …